TW200640449A - Pharmaceutical compositions and methods - Google Patents

Pharmaceutical compositions and methods

Info

Publication number
TW200640449A
TW200640449A TW095105171A TW95105171A TW200640449A TW 200640449 A TW200640449 A TW 200640449A TW 095105171 A TW095105171 A TW 095105171A TW 95105171 A TW95105171 A TW 95105171A TW 200640449 A TW200640449 A TW 200640449A
Authority
TW
Taiwan
Prior art keywords
methods
pharmaceutical compositions
disclosed
effective amount
composition
Prior art date
Application number
TW095105171A
Other languages
English (en)
Chinese (zh)
Inventor
Vinod V Tuliani
Michael A Brandley
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of TW200640449A publication Critical patent/TW200640449A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW095105171A 2005-02-18 2006-02-16 Pharmaceutical compositions and methods TW200640449A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65427905P 2005-02-18 2005-02-18
US69612105P 2005-07-01 2005-07-01

Publications (1)

Publication Number Publication Date
TW200640449A true TW200640449A (en) 2006-12-01

Family

ID=36917125

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095105171A TW200640449A (en) 2005-02-18 2006-02-16 Pharmaceutical compositions and methods

Country Status (4)

Country Link
AR (1) AR054226A1 (fr)
PE (1) PE20061010A1 (fr)
TW (1) TW200640449A (fr)
WO (1) WO2006089215A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE113956T1 (de) * 1989-09-22 1994-11-15 Fournier Ind & Sante Benzopyranon-beta-d-thioxyloside, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
FR2801055B1 (fr) * 1999-11-17 2002-02-08 Fournier Ind & Sante Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
WO2006089215A3 (fr) 2006-11-23
WO2006089215A2 (fr) 2006-08-24
AR054226A1 (es) 2007-06-13
PE20061010A1 (es) 2006-11-11

Similar Documents

Publication Publication Date Title
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
TW200716628A (en) Novel compounds
WO2008124085A3 (fr) Méthodes d'utilisation de combinaisons d'inhibiteurs de mek et de jak-2
MX2009003727A (es) Acidos y esteres boronicos como inhibidores de amida hidrolasa de acido graso.
WO2008063768A3 (fr) Compositions et procédés pour traiter des maladies métaboliques
TW200740799A (en) Alpha2C adrenoreceptor agonists
WO2007143607A3 (fr) Procédé de traitement de la vaginite atrophique
NZ609344A (en) Method for treatment of diarrhea-predominant irritable bowel syndrome
MX338338B (es) Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias.
WO2006038226A3 (fr) Compositions de metformine fortement compressibles a liberation controlee
MX2009011867A (es) Nuevos inhibidores macrociclicos de la replicacion del virus de hepatitis c.
EA200900155A1 (ru) Модуляторы фармакокинетических свойств лекарственных средств
WO2008005511A3 (fr) Nouveaux inhibiteurs de la réplication du virus de l'hépatite c
EP1880719A3 (fr) Composition pour la prophylaxie ou le traitement des infections du système urinaire et son procédé associé
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
WO2007082808A3 (fr) Thiazoles en tant qu'inhibiteurs de 11 beta-hsd1
UA96308C2 (ru) Антагонисты рецептора глюкагона, композиция, которая содержит такие соединения, и их применение
TN2011000415A1 (en) Pharmaceutical composition comprising a sglt2 inhibitor a dpp-i v inhibitor and optionally a further antidiabetic agent and uses thereof
NZ601248A (en) Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
UA100007C2 (ru) Гетероциклические ингибиторы мек, их применение и фармацевтическая композиция, которая их содержит
GEP20125458B (en) Matrix metalloproteinase inhibitors
WO2007112272A3 (fr) Formulations de diclofénac et de cyclodextrine bêta à faible dosage
WO2008042480A3 (fr) Inhibiteurs époxyde de cystéine protéases
GEP20115348B (en) Pharmaceutical composition for treating burns (variants) and methods for the production thereof (variants)
TNSN08506A1 (en) Substituted carboxamides